RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Prestige Consumer Healthcare Stock

Prestige Consumer Healthcare P/S 2024

Prestige Consumer Healthcare P/S

2.85

Ticker

PBH

ISIN

US74112D1019

WKN

A0DN17

As of Oct 4, 2024, Prestige Consumer Healthcare's P/S ratio stood at 2.85, a 13.55% change from the 2.51 P/S ratio recorded in the previous year.

The Prestige Consumer Healthcare P/S history

Prestige Consumer Healthcare Aktienanalyse

What does Prestige Consumer Healthcare do?

Prestige Consumer Healthcare Inc. is a global health company that focuses on the development, manufacturing, and marketing of various OTC medications, dietary supplements, and cosmetics. The company is headquartered in Tarrytown, New York and was founded in 1996. Prestige Consumer Healthcare Inc. has become one of the leading companies in the over-the-counter market over the years and has gained worldwide recognition. The company's formation can be traced back to the acquisition of various brands by Irvington Ventures, which later merged into Prestige Brands International. The business model of Prestige Consumer Healthcare Inc. is designed to provide affordable and effective products. The company strives to offer its customers high-quality products that are capable of effectively meeting their needs. Through continuous research and development, Prestige Consumer Healthcare Inc. is always able to respond to changes in the industry and the needs of its customers. Prestige Consumer Healthcare Inc. has various divisions specializing in providing products in different healthcare areas. These include pain management, cough and cold, gastrointestinal health, allergies and sinus, and skincare. Within each division, the company offers a wide range of products tailored to different customer needs. The product range of Prestige Consumer Healthcare Inc. includes well-known brands such as BC Powder, Chloraseptic, Clear Eyes, Dramamine, Little Remedies, DenTek, Nix, and Comet. Each of these brands has proven to be reliable and effective in treating various health issues. In addition, the company also produces dietary supplements such as the well-known US brand Osteo Bi-Flex, which treats joint problems, and Forté Elements, specifically developed for athletes and sports enthusiasts, as well as a wide range of skincare products such as CeraVe and LaRoche-Posay. In recent years, Prestige Consumer Healthcare Inc. has also established a strong presence in the international market. The company operates sales offices in various countries and exports its products worldwide. By working with various distribution channels, the company manages to reach customers in different regions. In 2018, the company also expanded into the e-commerce industry. Prestige Consumer Healthcare Inc. acquired the e-commerce startup Clique Brands, which specializes in selling beauty and lifestyle products, to further drive growth in the e-commerce market. In summary, Prestige Consumer Healthcare Inc. is a company that focuses on providing high-quality and affordable health and beauty products. The company has a wide range of products in various divisions tailored to the different needs of its customers. Through continuous research and development and expansion into different markets, the company has achieved significant growth in recent years and established itself as one of the leading brands in the global OTC industry. Prestige Consumer Healthcare ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Prestige Consumer Healthcare's P/S Ratio

Prestige Consumer Healthcare's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Prestige Consumer Healthcare's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Prestige Consumer Healthcare's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Prestige Consumer Healthcare’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Prestige Consumer Healthcare stock

What is the price-to-earnings ratio of Prestige Consumer Healthcare?

The price-earnings ratio of Prestige Consumer Healthcare is currently 2.85.

How has the price-earnings ratio of Prestige Consumer Healthcare changed compared to last year?

The price-to-earnings ratio of Prestige Consumer Healthcare has increased by 13.55% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Prestige Consumer Healthcare high compared to other companies?

Yes, the price-to-earnings ratio of Prestige Consumer Healthcare is high compared to other companies.

How does an increase in the price-earnings ratio of Prestige Consumer Healthcare affect the company?

An increase in the price-earnings ratio of Prestige Consumer Healthcare would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Prestige Consumer Healthcare affect the company?

A decrease in the price-earnings ratio of Prestige Consumer Healthcare would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Prestige Consumer Healthcare?

Some factors that influence the price-earnings ratio of Prestige Consumer Healthcare are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Prestige Consumer Healthcare pay?

Over the past 12 months, Prestige Consumer Healthcare paid a dividend of 0.35 USD . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, Prestige Consumer Healthcare is expected to pay a dividend of 0 USD.

What is the dividend yield of Prestige Consumer Healthcare?

The current dividend yield of Prestige Consumer Healthcare is 0.49 %.

When does Prestige Consumer Healthcare pay dividends?

Prestige Consumer Healthcare pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Prestige Consumer Healthcare?

Prestige Consumer Healthcare paid dividends every year for the past 5 years.

What is the dividend of Prestige Consumer Healthcare?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Prestige Consumer Healthcare located?

Prestige Consumer Healthcare is assigned to the 'Health' sector.

Wann musste ich die Aktien von Prestige Consumer Healthcare kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Prestige Consumer Healthcare from 10/15/2015 amounting to 0.345 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2015.

When did Prestige Consumer Healthcare pay the last dividend?

The last dividend was paid out on 10/15/2015.

What was the dividend of Prestige Consumer Healthcare in the year 2023?

In the year 2023, Prestige Consumer Healthcare distributed 0 USD as dividends.

In which currency does Prestige Consumer Healthcare pay out the dividend?

The dividends of Prestige Consumer Healthcare are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Prestige Consumer Healthcare

Our stock analysis for Prestige Consumer Healthcare Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Prestige Consumer Healthcare Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.